Serotonin, Serotonin Genetics(TPH2) and Emotion and Interference Processing
NCT03549182 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2020-12-22
Summary
The study aims to explore whether acute tryptophan depletion can affect the emotion and interference processing whether this effect is moderated by the TPH2 genotype
Conditions
- Healthy
Interventions
- DRUG
-
ATD treatment
oral administration of ATD (100g)(Acute Tryptophan Depletion)
- DRUG
-
placebo treatment
oral administration of placebo (102.3g)
Sponsors & Collaborators
-
University of Electronic Science and Technology of China
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-12-01
Countries
- China
Study Locations
More Related Trials
-
Serotonin and Everyday Social Interaction
NCT02051569 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Modulation of Visually Evoked Potentials by an Antidepressant
NCT00263133 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation
NCT05893173 ·Status: COMPLETED
-
Mood Effects of Serotonin Agonists Extended
NCT03934710 ·Status: COMPLETED ·Phase: PHASE1
-
Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder
NCT00955955 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating the Neuropsychological Effects of 5-HT2a Antagonism
NCT07022366 ·Status: RECRUITING ·Phase: NA
-
Antidepressant Discontinuation in Treatment Resistant Depression
NCT03786614 ·Status: UNKNOWN ·Phase: NA
-
7T Amygdala and Citalopram Study
NCT06412315 ·Status: RECRUITING ·Phase: NA
-
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
NCT00118014 ·Status: COMPLETED ·Phase: PHASE4
-
Examination of Brain Serotonin Receptors in Patients With Mood Disorders
NCT00026832 ·Status: COMPLETED
-
Intensive Accelerated iTBS for the Treatment-Resistant Depression
NCT06166082 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
NCT06306209 ·Status: RECRUITING
-
Pharmacogenetics of Antidepressant-Induced Disinhibition
NCT03953014 ·Status: RECRUITING
-
Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders
NCT01601912 ·Status: COMPLETED
-
Fluoxetine vs. Brief Psychotherapy for Major Depression
NCT00714779 ·Status: COMPLETED ·Phase: NA
-
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
NCT01710202 ·Status: COMPLETED
-
Tapering Off Antidepressants
NCT02661828 ·Status: TERMINATED ·Phase: NA
-
The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
NCT00451490 ·Status: WITHDRAWN ·Phase: NA
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00256113 ·Status: COMPLETED ·Phase: PHASE3
-
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT06827431 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Citalopram to Enhance Cognition in HD
NCT00271596 ·Status: COMPLETED ·Phase: PHASE2
-
Discontinuation of Antidepressant Medication in Primary Care.
NCT03361514 ·Status: COMPLETED ·Phase: NA
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)
NCT00321152 ·Status: COMPLETED ·Phase: PHASE4